Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novavax Gets the Job Done With its COVID Vaccine


In this video from Motley Fool Live recorded on Feb. 1, Fool.com contributors Brian Orelli and Keith Speights discussed phase 3 clinical trial data on Novavax's (NASDAQ: NVAX) coronavirus vaccine. The vaccine worked as well as the vaccine from Moderna (NASDAQ: MRNA) and the one from Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) against the original strain of the coronavirus. More importantly, Novavax's vaccine appears to protect participants from the U.K. variant, albeit to a lesser extent.

Continue reading


Source Fool.com

Like: 0
Share

Comments